Private Wealth Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Private Wealth Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.78K	Hold	24	–	–	﹤0.01%	792
2026 Q1	$4.54K	Hold	24	–	–	﹤0.01%	808
2025 Q4	$4.08K	Hold	24	–	–	﹤0.01%	855
2025 Q3	$3.16K	Hold	24	–	–	﹤0.01%	958
2025 Q2	$2.55K	Sell	24 -41	-63%	-$4.45K	﹤0.01%	1005
2025 Q1	$8.07K	Hold	65	–	–	﹤0.01%	544
2024 Q4	$8.01K	Sell	65 -10	-13%	-$1.18K	﹤0.01%	561
2024 Q3	$8.36K	Hold	75	–	–	﹤0.01%	513
2024 Q2	$8.01K	Buy	+75	New	+$8.25K	﹤0.01%	513

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Private Wealth Management Group's JAZZ Position: Q2 2026 in Review

Private Wealth Management Group held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 24 shares worth $5.78K. The position accounts for ﹤0.01% of the portfolio, ranked #792.

Private Wealth Management Group first reported a position in JAZZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.36K in Q3 2024. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Private Wealth Management Group held 24 shares of Jazz Pharmaceuticals worth $5.78K as of Q2 2026.
Private Wealth Management Group left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #792 holding.
Private Wealth Management Group first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Private Wealth Management Group's Jazz Pharmaceuticals position peaked at $8.36K in Q3 2024.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.